aesthetic
Glow
A triple-peptide aesthetic blend of GHK-Cu, TB-500, and BPC-157, formulated for coordinated dermal remodeling — targeting collagen architecture, vascular repair, and fibroblast activation through three distinct signaling pathways.
For research and laboratory use only. Not for human consumption.
Technical Data
Specifications
Technical Details
Quality Assurance
Certificate of Analysis
Certificate of Analysis
COA documentation is being prepared for this product.
Contact research@roehnrx.com for batch-specific testing data.
Research Overview
About Glow
Glow is a purpose-engineered aesthetic research formulation combining GHK-Cu (glycyl-L-histidyl-L-lysine copper complex), TB-500, and BPC-157 into a single co-lyophilized blend. Each component addresses a distinct axis of skin biology: GHK-Cu drives collagen I/III/IV synthesis and metalloproteinase-mediated matrix remodeling; TB-500 promotes endothelial cell migration and angiogenesis through actin dynamics; BPC-157 accelerates growth factor signaling and microvascular repair.
The scientific foundation for multi-peptide aesthetic formulations reflects the complexity of dermal tissue — effective regeneration requires simultaneous activation of structural protein synthesis, vascular supply restoration, and coordinated immune cell recruitment. Single-agent approaches address only one dimension; the Glow blend is designed to engage all three concurrently.
ROEHN formulates Glow with each component independently verified to 99% HPLC purity prior to co-lyophilization. The blend supports research at the intersection of cosmetic science and clinical dermatology — investigating peptide-mediated collagen architecture remodeling, skin barrier restoration, and targeted aesthetic outcomes through biochemical signaling rather than ablative interventions.
